Pemetrexed Dilution and Dosage
Pemetrexed 500 mg/m² should be reconstituted with preservative-free 0.9% sodium chloride to 25 mg/mL, then diluted in 100 mL of 0.9% sodium chloride for intravenous infusion over 10 minutes every 21 days, with mandatory dose reductions required for creatinine clearance <45 mL/min.
Standard Preparation and Administration
Reconstitution:
- Add preservative-free 0.9% sodium chloride to achieve 25 mg/mL concentration 1
- 100 mg vial: add 4.2 mL
- 500 mg vial: add 20 mL
- 1000 mg vial: add 40 mL
Dilution for Infusion:
- Further dilute the calculated dose in 100 mL of 0.9% sodium chloride 1
- Alternatively, 5% dextrose can be used, though 0.9% sodium chloride is preferred for stability 2, 3
- Administer as a 10-minute intravenous infusion 4, 5
Infusion Schedule:
- Standard dose: 500 mg/m² every 21 days 6, 7
- When combined with platinum agents: cisplatin 75 mg/m² or carboplatin AUC 5-6 on day 1 7
Critical Renal Dose Adjustments
Pemetrexed is contraindicated in patients with creatinine clearance <45 mL/min using standard dosing due to severe hematological toxicity risk 4, 8. The drug is primarily renally cleared, and impaired renal function dramatically increases drug exposure and toxicity 5.
Dose Modifications by Renal Function:
- CrCl ≥80 mL/min: 500-600 mg/m² (full dose) 4
- CrCl 40-79 mL/min: 500 mg/m² maximum 4
- CrCl <45 mL/min: Standard dosing contraindicated 8
For patients with CrCl 20-45 mL/min requiring treatment:
- Emerging evidence suggests AUC-based dosing with folinic acid prophylaxis (45 mg orally four times daily on days 2-15) may enable safe administration 9
- Doses as low as 20 mg total (not per m²) may be required for CrCl ~20 mL/min to achieve neutropenic-equivalent exposure 8
- This approach requires specialized pharmacokinetic monitoring and is not yet standard practice
Mandatory Supportive Care
All patients must receive:
- Folic acid 400-1000 mcg orally daily, beginning 7 days before first dose and continuing throughout treatment 6
- Vitamin B12 1000 mcg intramuscularly every 9 weeks, starting 7 days before first dose 6, 4
- Dexamethasone 4 mg orally twice daily for 3 days (day before, day of, and day after pemetrexed) to reduce skin rash 6
Without vitamin supplementation, hematologic toxicity rates increase substantially (18% vs 15% with supplementation in one study) 4.
Stability Considerations
Storage after dilution:
- Room temperature (20-25°C): Chemically stable for 48 hours, but limit to 24 hours to minimize microparticulate formation 3
- Refrigerated (2-8°C): Chemically stable for 31 days, but microparticulates form after 24 hours 3
- Recommendation: Use within 24 hours of preparation regardless of storage temperature 3
- Protect from light during storage 3
- Formulations containing hydroxypropyl-β-cyclodextrin show improved stability 2
Common Pitfalls to Avoid
Do not use in patients with CrCl <45 mL/min without specialized dosing protocols - this is the most critical safety consideration 8
Do not omit vitamin supplementation - this dramatically increases toxicity risk 4
Do not store diluted solutions beyond 24 hours - microparticulate formation occurs even though chemical stability persists 3
Do not use dextrose as the primary diluent - while chemically compatible, it may form degradation products and is less stable than normal saline 2, 3
Monitor for time above toxicity threshold - toxicity is driven by time above 0.110 mg/mL, not just peak concentration or AUC 8